Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort Study
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70150 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Bruce D Wilkie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Eastern Health, Box Hill, Victoria, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lymph Node Excision, Lymph Nodes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Medtronic, Australia, University of Melbourne, Australia, Medtronic.
Abstract (Originalsprache)
Background
The current standard for lymph node (LN) sampling in colorectal cancer (CRC) surgery is a minimum of 12 LNs. Emerging evidence suggests higher LN yields may improve disease‐free survival (DFS); however, an “optimal” number of LNs has yet to be definitively established. The aim of this study was to correlate LN yield with survival outcomes in patients undergoing surgery for nonmetastatic CRC.
Methods
The Bowel Cancer Outcomes Registry (BCOR) is a clinical quality registry in Australia and New Zealand. Post‐operative patients aged ≥ 18 years with histologically confirmed CRC, nonmetastatic disease at diagnosis and with follow‐up status documented were included. Post‐operative outcomes and survival were assessed with logistic regression. The primary endpoint was CRC‐specific mortality. Secondary endpoints were CRC recurrence and all‐cause mortality.
Results
Of 91 271 patient episodes, 10 616 individual eligible patients were identified (45.4% male, n = 4828). The median number of LNs resected was 18 [quartiles 0–12, 13–17, 18–23 and > 23]. A significant difference in CRC‐specific mortality was seen between quartiles ( p = 0.023), with the primary significant difference demonstrated between the lowest quartile (≤ 12 LNs) and other groups. On long‐term follow‐up, CRC recurrence and CRC‐specific mortality were higher in the group with ≤ 12 LNs resected (16.0% vs. 14.0%, adjusted p = 0.049 and 4.5% vs. 3.3%, adjusted p = 0.037 respectively).
Conclusion
This study supports the current consensus that > 12 LNs are required for adequate staging and oncological clearance in CRC surgery, and demonstrates yields ≤ 12 LNs are associated with higher CRC recurrence and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Eastern Health, Box Hill, Victoria, Australia.
- Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
- Department of General Surgery, Austin Health, Heidelberg, Victoria, Australia.
- Department of Cardiology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Bruce D Wilkie, James M Chan
Förderung
- Medtronic, Australia
- University of Melbourne, Australia
- Medtronic
- University of Melbourne
Zitieren
APA
Wilkie, B. D., Chan, J. M., Paratz, E., Proud, D., Smart, P., & An, V. (2025). Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort Study. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70150
Vancouver
Wilkie BD, Chan JM, Paratz E, Proud D, Smart P, An V. Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort Study. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70150
BibTeX
@article{Wilkie2025,
author = {Wilkie, Bruce D and Chan, James M and Paratz, Elizabeth and Proud, David and Smart, Philip and An, Vinna},
title = {Lymph Node Yield and Colorectal Cancer Survival: A Bowel Cancer Outcomes Registry Cohort Study},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70150}
}
EUVIMED